Immunis, Inc. is a private, clinical-stage biotechnology company headquartered in Irvine, California, developing immunomodulatory secretome biologics — the mixture of proteins and factors secreted by stem cells, rather than the cells themselves — as a treatment for age- and disease-related immune decline. Its lead candidate, IMM01-STEM, is under study in the STEM-MYO Phase 1/2a trial for muscle atrophy and sarcopenia, alongside a STEM-META Phase 2 program and a STEM-K9 veterinary program. Immunis is a therapeutics developer, not a software company: it publishes no developer portal, API, SDK, webhook surface, or machine-readable API contract of any kind. Its entire public surface is a WordPress marketing and clinical-trial-recruitment site whose only machine-readable endpoint is the default WordPress REST API at /wp-json/, which serves the CMS of that site and is not an Immunis API product.
Immunis is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Therapeutics, and Clinical Trials.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/immunis: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: immunis
name: Immunis
description: 'Immunis, Inc. is a private, clinical-stage biotechnology company headquartered in Irvine, California, developing
immunomodulatory secretome biologics — the mixture of proteins and factors secreted by stem cells, rather than the cells
themselves — as a treatment for age- and disease-related immune decline. Its lead candidate, IMM01-STEM, is under study
in the STEM-MYO Phase 1/2a trial for muscle atrophy and sarcopenia, alongside a STEM-META Phase 2 program and a STEM-K9
veterinary program. Immunis is a therapeutics developer, not a software company: it publishes no developer portal, API,
SDK, webhook surface, or machine-readable API contract of any kind. Its entire public surface is a WordPress marketing and
clinical-trial-recruitment site whose only machine-readable endpoint is the default WordPress REST API at /wp-json/, which
serves the CMS of that site and is not an Immunis API product.'
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://immunisbiomedical.com/wp-content/uploads/2026/06/ImmunisLogo.png
url: https://raw.githubusercontent.com/api-evangelist/immunis/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-23'
modified: '2026-08-23'
tags:
- Company
- Biotechnology
- Life Sciences
- Therapeutics
- Clinical Trials
- Regenerative Medicine
- Healthcare
- Longevity
- Sarcopenia
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/immunis-domain-security.yml
- type: LLMsTxt
url: llms/immunis-llms.txt
- type: Website
url: https://immunisbiomedical.com/
- type: PressReleases
url: https://immunisbiomedical.com/press-releases/
- type: Contact
url: https://immunisbiomedical.com/contact/
- type: LinkedIn
url: https://www.linkedin.com/company/immunisbiomedical/
x-enrichment:
date: '2026-08-23'
status: minimal
artifacts_added: 3
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: Immunis, Inc. is a clinical-stage biotech developing secretome therapeutics; its full page inventory (46 pages,
read from the site's own sitemap) contains no developer, API or documentation page, and every /openapi.json, /api-docs,
/graphql, /llms.txt and /.well-known/* probe on immunisbiomedical.com returned the WordPress 404 page — the only machine-readable
endpoint on the host is the site's default WordPress CMS REST API at /wp-json/.
evidence:
- url: https://immunisbiomedical.com/openapi.json
status: 404
- url: https://immunisbiomedical.com/.well-known/api-catalog
status: 404
- url: https://immunisbiomedical.com/llms.txt
status: 404
- url: https://immunisbiomedical.com/developers
status: 404
- url: https://immunisbiomedical.com/wp-json/
status: 200
checked: '2026-08-23'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →